【Introduction】   This product is used for positron emission tomography (PET) to identify areas of altered osteogenic activity in bone imaging. Bone metastasis is a common complication of advanced tumors, which can cause refractory pain, pathological fractures, spinal cord compression, hypercalcemia, and other bone related events, seriously reducing patients' ability to move independently and quality of life, and threatening their survival.

【Advantages】   The bone uptake process of fluoride [¹⁸F] sodium injection is faster and the examination time is shorter; Secondly, it does not participate in metabolic processes in the body and is mainly excreted through urine via the kidneys, reducing the conversion of drugs in the body and the occurrence of adverse reactions; Finally, it almost does not bind to plasma proteins, resulting in fast blood clearance and greatly reducing residual radiation in the body, thereby enhancing safety.